alpha-4/beta-1 integrin antagonists (Genentech)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Namealpha-4/beta-1 integrin antagonists (Genentech)
Drug Alias NameVCAM antagonists (Genentech)integrin antagonists (Genentech)VCAM-506VCAM-540
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionIntegrin alpha-4/beta-1 antagonists
TargetsIntegrin alpha-4/beta-1
Therapy Area/IndicationsMultiple SclerosisAsthmaInflammatory Bowel Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenentech Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenentech Inc
Active IndicationsN/A
Inactive IndicationsMultiple SclerosisAsthmaInflammatory Bowel Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A